These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1815006)
1. Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis. Schuppan D J Hepatol; 1991; 13 Suppl 3():S17-25. PubMed ID: 1815006 [TBL] [Abstract][Full Text] [Related]
2. [Connective tissue polypeptides in serum: new parameters of connective tissue synthesis and degradation in liver fibrosis]. Schuppan D Z Gastroenterol; 1992 Mar; 30 Suppl 1():29-34. PubMed ID: 1449013 [TBL] [Abstract][Full Text] [Related]
4. Measurement of connective tissue parameters in serum for diagnosis and follow-up of liver fibrosis. Gressner AM Ann Clin Biochem; 1987 May; 24 ( Pt 3)():283-92. PubMed ID: 3606014 [TBL] [Abstract][Full Text] [Related]
5. Hepatic fibrosis: are any of the serum markers useful? Oh S; Afdhal NH Curr Gastroenterol Rep; 2001 Feb; 3(1):12-8. PubMed ID: 11177689 [TBL] [Abstract][Full Text] [Related]
6. Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease. Stickel F; Urbaschek R; Schuppan D; Poeschl G; Oesterling C; Conradt C; McCuskey RS; Simanowski UA; Seitz HK Dig Dis Sci; 2001 Sep; 46(9):2025-32. PubMed ID: 11575459 [TBL] [Abstract][Full Text] [Related]
7. Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity. Lotterer E; Gressner AM; Kropf J; Grobe E; von Knebel D; Bircher J J Hepatol; 1992 Jan; 14(1):71-7. PubMed ID: 1737919 [TBL] [Abstract][Full Text] [Related]
8. Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. Hørslev-Petersen K; Bentsen KD; Halberg P; Junker P; Kivirikko KI; Majamaa K; Risteli L; Risteli J; Lorenzen I Clin Exp Rheumatol; 1988; 6(2):129-34. PubMed ID: 2846219 [TBL] [Abstract][Full Text] [Related]
9. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Niemelä O; Risteli J; Blake JE; Risteli L; Compton KV; Orrego H Gastroenterology; 1990 Jun; 98(6):1612-9. PubMed ID: 1692550 [TBL] [Abstract][Full Text] [Related]
10. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase? Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of extracellular matrix in acute pancreatitis. Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198 [TBL] [Abstract][Full Text] [Related]
12. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man. Bentsen KD; Lanng C; Hørslev-Petersen K; Risteli J Acta Chir Scand; 1988 Feb; 154(2):97-101. PubMed ID: 3354300 [TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of hepatic fibrosis. Plebani M; Burlina A Clin Biochem; 1991 Jun; 24(3):219-39. PubMed ID: 1651819 [TBL] [Abstract][Full Text] [Related]
14. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases. Lin DY; Chu CM; Sheen IS; Liaw YF Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy. von Moers A; Danne T; Möller P; Scheffner D Acta Paediatr; 1997 Apr; 86(4):377-80. PubMed ID: 9174223 [TBL] [Abstract][Full Text] [Related]
16. Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide. Hirayama C; Suzuki H; Takada A; Fujisawa K; Tanikawa K; Igarashi S J Gastroenterol; 1996 Apr; 31(2):242-8. PubMed ID: 8680545 [TBL] [Abstract][Full Text] [Related]
17. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease. Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224 [TBL] [Abstract][Full Text] [Related]
18. Collagen breakdown products as markers of fibrosis and cirrhosis. Niemelä O Alcohol Alcohol Suppl; 1994; 2():345-52. PubMed ID: 8974354 [TBL] [Abstract][Full Text] [Related]
19. Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases. Ueno T; Tamaki S; Sugawara H; Inuzuka S; Torimura T; Sata M; Tanikawa K J Hepatol; 1996 Feb; 24(2):177-84. PubMed ID: 8907571 [TBL] [Abstract][Full Text] [Related]
20. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]